{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:08:30Z","timestamp":1775041710262,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.vaccine.2008.08.062","type":"journal-article","created":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T17:01:49Z","timestamp":1221757309000},"page":"5899-5904","source":"Crossref","is-referenced-by-count":20,"title":["MeNZB\u2122 vaccine and epidemic control: When do you stop vaccinating?"],"prefix":"10.1016","volume":"26","author":[{"given":"Belinda J.","family":"Loring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikki","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Petousis-Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.08.062_bib1","series-title":"The epidemiology of meningococcal disease in New Zealand in 2006","author":"Martin","year":"2007"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2008.08.062_bib2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/aje\/kwm147","article-title":"A prospective study of the effectiveness of the New Zealand meningococcal B vaccine","volume":"166","author":"Kelly","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"77","key":"10.1016\/j.vaccine.2008.08.062_bib3","first-page":"331","article-title":"Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines. WHO position paper","volume":"40","author":"World Health Organisation","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.062_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.37757\/MR2007V9.N1.6","article-title":"Cuban meningococcal BC vaccine: experiences & contributions from 20 years of application","volume":"9","author":"Sotolongo","year":"2007","journal-title":"MEDICC Rev"},{"key":"10.1016\/j.vaccine.2008.08.062_bib5","unstructured":"Meningococcal Vaccine Strategy Team, Ministry of Health; 2007."},{"key":"10.1016\/j.vaccine.2008.08.062_bib6","series-title":"Immunisation handbook 2006","author":"New Zealand Ministry of Health","year":"2006"},{"issue":"11","key":"10.1016\/j.vaccine.2008.08.062_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/CVI.00167-07","article-title":"Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens","volume":"14","author":"Hosking","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2008.08.062_bib8","series-title":"Meningococcal disease report: December 2007","author":"Lopez","year":"2007"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2008.08.062_bib9","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/IAI.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"Milagres","year":"1994","journal-title":"Infect Immun"},{"issue":"March (17\u201318)","key":"10.1016\/j.vaccine.2008.08.062_bib10","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2014serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2008.08.062_bib11","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1128\/CVI.00341-07","article-title":"Immunity to Neisseria meningitides group B in adults despite lack of serum bactericidal antibody","volume":"14","author":"Welsch","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2008.08.062_bib12","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/508780","article-title":"Vaccine prevention of meningococcal disease: making slow progress (editorial commentary)","volume":"43","author":"Harrison","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"March (17\u201318)","key":"10.1016\/j.vaccine.2008.08.062_bib13","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.vaccine.2005.01.048","article-title":"Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand: a multi-faceted strategy","volume":"23","author":"Ameratunga","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.062_bib14","unstructured":"Sexton K, Lennon D, Oster P, Aaberge I, Martin D, Reid S, et al. Proceedings of the meningococcal vaccine strategy World Health Organization satellite meeting, 10 March 2004, Auckland, New Zealand [see comment]. New Zealand Med J 2004;117 (August (1200)):1. p. preceding U1027."},{"issue":"April (16)","key":"10.1016\/j.vaccine.2008.08.062_bib15","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.vaccine.2007.01.023","article-title":"Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand","volume":"25","author":"Oster","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.062_bib16","series-title":"Interscience conference on antimicrobial agents and chemotherapy","article-title":"Persistence of immune response in New Zealand adults and children after 3 doses of MeNZB and response to a 4th dose in toddlers","author":"Jackson","year":"2007"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2008.08.062_bib17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1128\/CVI.00047-06","article-title":"Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine","volume":"13","author":"Feiring","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2008.08.062_bib18","unstructured":"CBG Health Research. Evaluation of meningococcal B immunisation national roll out final report auckland: report prepared for the New Zealand Ministry of Health; November 2006."},{"key":"10.1016\/j.vaccine.2008.08.062_bib19","unstructured":"Ministry of Health. Immunisation: questions and answers on the pneumococcal conjugate vaccine; 2007."},{"key":"10.1016\/j.vaccine.2008.08.062_bib20","unstructured":"The New Zealand Medicines and Medical Devices Safety Authority. MeNZB Data Sheet; 2006."},{"issue":"March (12)","key":"10.1016\/j.vaccine.2008.08.062_bib21","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.vaccine.2006.11.032","article-title":"Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998\u20132006)","volume":"25","author":"Oosterhuis-Kafeja","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.062_bib22","series-title":"Conjugate pneumococcal vaccine for children. Auckland: Immunisation Advisory Centre","author":"Reid","year":"2006"},{"key":"10.1016\/j.vaccine.2008.08.062_bib23","series-title":"An economic evaluation of vaccination against meningococcal disease Auckland","author":"Milne","year":"2001"},{"key":"10.1016\/j.vaccine.2008.08.062_bib24","unstructured":"Ministry of Health. Immunisation coverage at milestone age (18 months of age). Reporting period: 3 month period ending March 2008. April 24, 2008 [cited May 9, 2008]. Available from: http:\/\/www.moh.govt.nz\/moh.nsf\/indexmh\/immunisation-coverage-data."},{"key":"10.1016\/j.vaccine.2008.08.062_bib25","unstructured":"Institute of Environmental Science and Research Limited. Meningococcal Epidemiology Data (special request). Wellington; 2007."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:23:23Z","timestamp":1684542203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08011602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":25,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0264410X08011602"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}